Vesalius Longevity Labs (SPV) Inc. funding
Vesalius Longevity Labs (SPV) Inc., a biotechnology company based in Vancouver, British Columbia, Canada (founded 2024), filed a Form D with the SEC on March 19, 2026 and reported $6.7M raised.
Amount raised$6.7M
Offering size$6.7M
Filed with the SECMarch 19, 2026
First saleMarch 11, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationVancouver, British Columbia, Canada
Founded2024
Entity typeCorporation
Investors so far19
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 19
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology